LONDON - Brussels on Wednesday published a long-awaited draft of its proposed overhaul of laws governing the European Union’s pharmaceuticals industry, setting up a tussle with drugmakers which warn they will invest and innovate elsewhere.
The Commission proposes to cut the length of basic market exclusivity that drugmakers get before generics can enter the market from 10 to eight years. Following publication, the European Parliament, Commission and member states will now thrash out final details of the law, which could take years.
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む: